RCA’s Research Institute is making strides in clinical trials.

/ , /by

Dr. Mark Barakat discusses how clinical trials are helping patients maintain their vision.

Read the Article on AZCentral

 

Dr. Mark Barakat discusses developments in gene therapy for neovascular AMD

/ , /by

Watch Dr. Mark Barakat discuss the suprachoroidal delivery of a tyrosinase kinase inhibitor and a gene therapy agent for the treatment of neovascular AMD.

Dr. Mark Barakat first in AZ to administer new gene therapy for AMD

/ , /by

Watch Dr. Mark R. Barakat sit down with CBS to talk about being the first in AZ to administer gene therapy to treat Age-related Macular Degeneration.

Watch the CBC Interview!

Dr. Mark Barakat’s discusses the Kingfisher Trial of Brolucizumab for DME

/ , /by

Watch Dr. Mark R. Barakat discuss the results of the Kingfisher trail, a study employing broluizumab for the treatment of diabetic macular edema with Retina Synthesis.